Post Traumatic Pain Clinical Trial
Official title:
The Incidence and Strenght of Pain in Conscious Multitrauma Patients, 0-14 Days After Multitrauma
| Verified date | November 2018 |
| Source | Oslo University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
To register the perceived pain score during 0-14 days after multitrauma in conscious patients and to register the use (type and dose) of analgesic treatment in the same period.
| Status | Recruiting |
| Enrollment | 40 |
| Est. completion date | November 1, 2019 |
| Est. primary completion date | March 2019 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Patient With trauma, ISS > 8 Exclusion Criteria: - Unconscious patients at admission - patients due for major surgery within 3 hrs of admission - patients primary admitted to other hospitals - not able to communicate in Norewegian |
| Country | Name | City | State |
|---|---|---|---|
| Norway | Dept of Anesthesiology, Oslo University Hospital, Ullevaal | Oslo |
| Lead Sponsor | Collaborator |
|---|---|
| Oslo University Hospital |
Norway,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Worst pain | NRS scale, 0-10 | 0-14 days | |
| Primary | Average pain | NRS scale, 0-10 | 0-14 days | |
| Secondary | analgesic methods | list of drugs (dose and duration) and other analgesic measures | 0-14 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01123551 -
Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain
|
Phase 3 |